Healwell AIHAM:6H90 +1.87%65 EBITDA Margin % is 3.92% as of Mar. 2026. GuruFocus rates HAM:6H90 with a GF Score™ of 65/100 and a GF Value™ of €2.27 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Healwell AI ranks worse than 75.64% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Healwell AI's EBITDA for the
three
months ended in Mar. 2026 was €0.82 Mil. Healwell AI's Revenue for the
three
months ended in Mar. 2026 was €20.94 Mil. Therefore, Healwell AI's EBITDA margin for the quarter that ended in Mar. 2026 was 3.92%.
Healwell AI (HAM:6H90) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Healwell AI EBITDA Margin % Related Terms
Healwell AI EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Healwell AI's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:6H90 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Healwell AI's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healwell AI EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Healwell AI's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Healwell AI's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healwell AI (HAM:6H90) has a EBITDA Margin % of 3.92% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Healwell AI and its competitors. According to the industry distribution chart, Healwell AI ranks #503 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 75.6%.
Is Healwell AI's EBITDA Margin % too high?
Healwell AI's current EBITDA Margin % is 3.92%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Healwell AI's value of 3.92% is 61.7% below this industry median. Based on the distribution chart, Healwell AI ranks #503 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Healwell AI has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Healwell AI's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Healwell AI ranks #503 out of 665 companies for EBITDA Margin %. This places Healwell AI in the lower half of its industry. The industry median EBITDA Margin % is 10.24. Healwell AI's value of 3.92% is 61.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healwell AI's current EBITDA Margin % of 3.92% is 61.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Healwell AI and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healwell AI's current EBITDA Margin % is 3.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healwell AI stock overvalued right now?
Based on GuruFocus' analysis, Healwell AI (HAM:6H90) is currently considered Possible Value Trap. The stock's GF Value™ is €2.27, compared to a current price of €0.49 — trading 78.4% below its estimated fair value. The current EBITDA Margin % is 3.92% and 61.7% below the Healthcare Providers & Services industry median of 10.24. Healwell AI's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Healwell AI (HAM:6H90), the current EBITDA Margin % is 3.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healwell AI (HAM:6H90) Overvalued in 2026?
Based on GuruFocus' analysis, Healwell AI stock appears to be undervalued.
The current stock price of €0.49 is trading 78.4% below its estimated GF Value™ of €2.27.
GuruFocus considers Healwell AI to be Possible Value Trap.
Key valuation signals for HAM:6H90:
EBITDA Margin %: 3.92%
GF Value™: €2.27 vs. price of €0.49 (78.4% below fair value)
Industry Position: 61.7% below the Healthcare Providers & Services median (#503 of 665)
No single metric tells the full story. See the HAM:6H90 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healwell AI Inc is a Canadian healthcare technology company. It operates in two reportable segments: Al and Data Sciences, and Healthcare Software. The majority of Healwell's revenue is generated from the Healthcare Software segment, whose core software suite consists of Electronic Health Records (EHR), Digital Front Door (DFD), and Digital Care Records (DCR). These products consolidate diverse data sources, helping physicians get a comprehensive view of individual patient health. The AI and Data Sciences division offers AI technologies and algorithms that screen clinical information and patient records, and aid in identifying patients at high risk for specific conditions. Geographically, the company generates maximum revenue from Australia and New Zealand, and the rest from Canada.
65GF Score
Get the complete analysis for HAM:6H90
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:6H90 has been successfully added to your 
